Palazestrant
Product Specifications
CAS Number
2092925-89-6
Synonyms
OP-1250
Target
Estrogen/progestogen Receptor
Applications
Endocrinology & Hormones
Molecular Formula
C28H36FN3O
Additionnal Information
Palazestrant (OP-1250) is an orally bioavailable complete antagonist of estrogen receptor (ER) that blocks ER activity. It exhibits antiproliferative and antitumor activity in ER-positive (ER+) breast cancer models.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
D2237 96 Tests
Epithelial-stromal interaction protein 1 (EPSTI1) Rat ELISA Kit
Sign In for Pricing
View Details 
PTX19234-01 50 µg
Anti-Phospho-Vimentin (pS56) Monoclonal Antibody, 4A4
Sign In for Pricing
View Details PTX19234-02 100 µg
Anti-Phospho-Vimentin (pS56) Monoclonal Antibody, 4A4
Sign In for Pricing
View Details PTX19234-03 1 mg
Anti-Phospho-Vimentin (pS56) Monoclonal Antibody, 4A4
Sign In for Pricing
View Details 